Renaissance Technologies’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Renaissance Technologies's TRAX Position: Q3 2026 in Review
Renaissance Technologies opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 42,700 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #2090 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Renaissance Technologies held 42,700 shares of First Tracks Biotherapeutics worth $1.51M as of Q3 2026.
- First Tracks Biotherapeutics was a new Renaissance Technologies position in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2090 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.